{"id":"https://openalex.org/W2761662574","doi":"https://doi.org/10.1007/s40264-017-0606-2","title":"Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England","display_name":"Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England","publication_year":2017,"publication_date":"2017-10-10","ids":{"openalex":"https://openalex.org/W2761662574","doi":"https://doi.org/10.1007/s40264-017-0606-2","mag":"2761662574","pmid":"https://pubmed.ncbi.nlm.nih.gov/29019038"},"language":"en","primary_location":{"id":"doi:10.1007/s40264-017-0606-2","doi":"https://doi.org/10.1007/s40264-017-0606-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40264-017-0606-2","pdf_url":null,"source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028813287","display_name":"Vicki Osborne","orcid":"https://orcid.org/0000-0002-3669-6084","observed_orcids":["https://orcid.org/0000-0002-3669-6084"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210140975","display_name":"Drug Safety Research Unit","ror":"https://ror.org/04a8rag37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210140975"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Vicki Osborne","raw_affiliation_strings":["Department of Epidemiology, University of Florida, Gainesville, FL, USA","Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK"],"raw_orcid":"https://orcid.org/0000-0002-3669-6084","affiliations":[{"raw_affiliation_string":"Department of Epidemiology, University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]},{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK","institution_ids":["https://openalex.org/I4210140975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010753379","display_name":"Miranda Davies","orcid":"https://orcid.org/0000-0003-2949-8378","observed_orcids":["https://orcid.org/0000-0003-2949-8378"]},"institutions":[{"id":"https://openalex.org/I4210140975","display_name":"Drug Safety Research Unit","ror":"https://ror.org/04a8rag37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210140975"]},{"id":"https://openalex.org/I63072094","display_name":"University of Portsmouth","ror":"https://ror.org/03ykbk197","country_code":"GB","type":"education","lineage":["https://openalex.org/I63072094"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Miranda Davies","raw_affiliation_strings":["Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK","School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK","institution_ids":["https://openalex.org/I4210140975"]},{"raw_affiliation_string":"School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK","institution_ids":["https://openalex.org/I63072094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082637236","display_name":"Deborah Layton","orcid":"https://orcid.org/0000-0002-8557-1376","observed_orcids":["https://orcid.org/0000-0002-8557-1376","https://orcid.org/0009-0008-2080-044X"]},"institutions":[{"id":"https://openalex.org/I4210140975","display_name":"Drug Safety Research Unit","ror":"https://ror.org/04a8rag37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210140975"]},{"id":"https://openalex.org/I63072094","display_name":"University of Portsmouth","ror":"https://ror.org/03ykbk197","country_code":"GB","type":"education","lineage":["https://openalex.org/I63072094"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Deborah Layton","raw_affiliation_strings":["Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK","School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK","institution_ids":["https://openalex.org/I4210140975"]},{"raw_affiliation_string":"School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK","institution_ids":["https://openalex.org/I63072094"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004126637","display_name":"Saad Shakir","orcid":"https://orcid.org/0000-0002-4084-297X","observed_orcids":["https://orcid.org/0000-0002-4084-297X"]},"institutions":[{"id":"https://openalex.org/I4210140975","display_name":"Drug Safety Research Unit","ror":"https://ror.org/04a8rag37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210140975"]},{"id":"https://openalex.org/I63072094","display_name":"University of Portsmouth","ror":"https://ror.org/03ykbk197","country_code":"GB","type":"education","lineage":["https://openalex.org/I63072094"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Saad A. W. Shakir","raw_affiliation_strings":["Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK. saad.shakir@dsru.org","School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK. saad.shakir@dsru.org","Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK. saad.shakir@dsru.org","institution_ids":["https://openalex.org/I4210140975"]},{"raw_affiliation_string":"School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK. saad.shakir@dsru.org","institution_ids":["https://openalex.org/I63072094"]},{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK","institution_ids":["https://openalex.org/I4210140975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5004126637"],"corresponding_institution_ids":["https://openalex.org/I4210140975","https://openalex.org/I63072094"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":1.1648,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.76935615,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"41","issue":"3","first_page":"267","last_page":"275"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.8881999850273132,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.8881999850273132,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.04259999841451645,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.030300000682473183,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/deferasirox","display_name":"deferasirox","score":0.9990000128746033},{"id":"https://openalex.org/keywords/iron-chelation","display_name":"iron chelation","score":0.949999988079071},{"id":"https://openalex.org/keywords/chronic-iron-overload","display_name":"chronic iron overload","score":0.7699999809265137},{"id":"https://openalex.org/keywords/transfusion-dependent-anemia","display_name":"transfusion-dependent anemia","score":0.7630000114440918},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/beta-thalassemia","display_name":"beta-thalassemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.7070000171661377},{"id":"https://openalex.org/keywords/serum-creatinine","display_name":"serum creatinine","score":0.7350000143051147},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6610000133514404},{"id":"https://openalex.org/keywords/primary-care-prescribing","display_name":"primary care prescribing","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C2781053155","wikidata":"https://www.wikidata.org/wiki/Q5251502","display_name":"Deferasirox","level":3,"score":0.9831118583679199},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9426580667495728},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7012286186218262},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6353267431259155},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.606122612953186},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.5306795239448547},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5156211256980896},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5050142407417297},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4063591957092285},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.24125295877456665},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.12856295704841614}],"mesh":[{"descriptor_ui":"D000077588","descriptor_name":"Deferasirox","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004739","descriptor_name":"England","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019190","descriptor_name":"Iron Overload","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058006","descriptor_name":"General Practice","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s40264-017-0606-2","doi":"https://doi.org/10.1007/s40264-017-0606-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40264-017-0606-2","pdf_url":null,"source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},{"id":"pmid:29019038","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29019038","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug safety","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:drugsa:v:41:y:2018:i:3:d:10.1007_s40264-017-0606-2","doi":null,"is_oa":false,"landing_page_url":"http://link.springer.com/10.1007/s40264-017-0606-2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332756","display_name":"Novartis Pharmaceuticals UK Limited","ror":"https://ror.org/039s6n838"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W74922302","https://openalex.org/W1581830258","https://openalex.org/W1850973663","https://openalex.org/W1985505791","https://openalex.org/W2010786659","https://openalex.org/W2035430975","https://openalex.org/W2326363965","https://openalex.org/W2498038894","https://openalex.org/W2516679218","https://openalex.org/W2557836944","https://openalex.org/W3206486718"],"related_works":["https://openalex.org/W2364511414","https://openalex.org/W2800189181","https://openalex.org/W2127565324","https://openalex.org/W2460394139","https://openalex.org/W2785306560","https://openalex.org/W4387348418","https://openalex.org/W2587027548","https://openalex.org/W2035594167","https://openalex.org/W1974629977","https://openalex.org/W2007537333"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-10-20T00:00:00"}